Arvinas (ARVN) Receivables (2017 - 2026)
Arvinas (ARVN) posted Receivables of $54.3 million for Q2 2026, up 389.2% from $11.1 million a year earlier and up 748.4% from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) Receivables (2017 - 2026) Analysis & Trends
At the end of FY2025, Arvinas' Receivables came in at $6.4 million, down 53.3% from FY2024.
- Annual Receivables shows a five-year compound annual growth rate of -5.3% (FY2020 to FY2025).
- In prior years, Arvinas' Receivables was $13.7 million in FY2024 (+90.3%), $7.2 million in FY2023 (-10.0%), $8 million in FY2022 (-68.9%) and $25.7 million in FY2021 (+206.0%).
- The Q2 2026 figure stands as the highest quarterly Receivables in data going back to Q4 2017.
- On a year-over-year basis, Receivables increased in four of the last eight quarters, with growth averaging 58.5%.
- The strongest year-over-year quarter for Receivables in the past five years was Q2 2026, with growth of 389.2%; the weakest was Q4 2022, with a decline of 68.9%.
- According to Business Quant data, Receivables for the three prior quarters was $6.4 million (Q1 2026), $6.4 million (Q4 2025) and $26.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Arvinas | 490.40 Mn | -2.17 Bn | - | 54.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.30 Mn |
| Mar 31, 2026 | 6.40 Mn |
| Dec 31, 2025 | 6.40 Mn |
| Sep 30, 2025 | 26.80 Mn |
| Jun 30, 2025 | 11.10 Mn |
| Mar 31, 2025 | 8.40 Mn |
| Dec 31, 2024 | 13.70 Mn |
| Sep 30, 2024 | 14.80 Mn |
| Jun 30, 2024 | 11.80 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Dec 31, 2023 | 7.20 Mn |
| Sep 30, 2023 | 20.60 Mn |
| Jun 30, 2023 | 4.80 Mn |
| Mar 31, 2023 | 4.70 Mn |
| Dec 31, 2022 | 8.00 Mn |
| Sep 30, 2022 | 6.80 Mn |
| Jun 30, 2022 | 8.10 Mn |
| Mar 31, 2022 | 6.70 Mn |
| Dec 31, 2021 | 25.70 Mn |
| Sep 30, 2021 | 8.66 Mn |
API Access
Arvinas Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();